Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
AIMS: Patients with asymptomatic and undiagnosed atrial fibrillation (AF) are at increased risk of heart failure and ischaemic stroke. In this study, we validated a new diagnostic device, the MyDiagnostick, for detection of AF by general practitioners and patients. It records and stores a Lead I electrocardiogram (ECG) which is automatically analysed for the presence of AF. METHODS AND RESULTS: In total, 192 patients (age 69.4 ± 12.6 years) were asked to hold the MyDiagnostick for 1 min, immediately before a routine 12-lead ECG was recorded. Atrial fibrillation detection and ECGs stored by the MyDiagnostick were compared with the cardiac rhythm on the 12-lead ECG. In a second part of the study, the MyDiagnostick was used to screen for AF during influenza vaccination in the general practitioner's office. Atrial fibrillation was present in 53 out of the 192 patients (27.6%). All AF patients were correctly detected by the MyDiagnostick (sensitivity 100%; 95% confidence interval 93-100%). MyDiagnostick AF classification in 6 out of 139 patients in sinus rhythm was considered false positive (specificity 95.9%; 95% confidence interval 91.3-98.1%). During 4 h of influenza vaccination in 676 patients (age 74 ± 7.1 years), the MyDiagnostick correctly diagnosed AF in all 55 patients (prevalence 8.1%). In 11 patients (1.6%), AF was not diagnosed before, all with a CHA2DS2VASc score of >1. CONCLUSION: The high AF detection performance of the MyDiagnostick, combined with the ease of use of the device, enables large screening programmes for detection of undiagnosed AF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several patientoperated devices 136,137 and extended continuous ECG monitoring using skin patch recorders 138 have been validated for detection of paroxysmal AF. 139”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [137]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Developed with the special contribution of the European Heart Rhythm Association (EHRA), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Authors/Task Force Members, Camm, A. J., Kirchhof, P., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Van Gelder, I. C., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,864
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P., ESC Committee for Practice Guidelines (CPG), et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,822
Subclinical atrial fibrillation and the risk of stroke
Healey, J. S., Connolly, S. J., Gold, M. R., Israel, C. W., Van Gelder, I. C., Capucci, A., Lau, C. P., Fain, E., Yang, S., Bailleul, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105575 · Cited by 2,100 · cited 13×
“Another costeffective indication could be outpatient cardiac monitoring for identification of paroxysmal AF in patients after ischaemic stroke.19 The use of the MyDiagnostick in opportunistic screening may also improve the identification of asymptomatic patients with AF.”
BackgroundInfluentialPrevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study
Heeringa, J., van der Kuip, D. A. M., Hofman, A., Kors, J. A., van Herpen, G., Stricker, B. H. C., Stijnen, T., Lip, G. Y. H., & Witteman, J. C. M. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi825 · Cited by 1,939 · cited 1×
“8% in those aged ≥85 years.(1) With ageing populations, the prevalence of AF will increase substantially during thenextdecennia.”
BackgroundGuidelines for the management of atrial fibrillation
Developed with the special contribution of the European Heart Rhythm Association (EHRA), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Authors/Task Force Members, Camm, A. J., Kirchhof, P., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Van Gelder, I. C., et al. (2010) · EP Europace · doi:10.1093/europace/euq350 · Cited by 1,747
2012 Focused Update of the ESC Guidelines for the Management of Atrial Fibrillation
Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., & Kirchhof, P. (2013) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2012.11.003 · Cited by 687
Jabaudon, D., Sztajzel, J., Sievert, K., Landis, T., & Sztajzel, R. (2004) · Stroke · doi:10.1161/01.str.0000131269.69502.d9 · Cited by 414
Research works printed but not linked: 5
- 2013, International journal of cardiology, 164, 371, 10.1016/j.ijcard.2012.08.002 · DOI
- 2009, New England Journal of Medicine, 361, 1139, 10.1056/NEJMoa0905561 · DOI · Paper page
- Barth l my, 2003, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 8, 194, 10.1046/j.1542-474X.2003.08305.x · DOI · Paper page
- 2013, International journal of cardiology, 165, 193, 10.1016/j.ijcard.2013.01.220 · DOI · Paper page
- 2009, American Journal of Hypertension, 22, 848, 10.1038/ajh.2009.98 · DOI · Paper page
Cited by
Items 101–138 of 138
Jones, I. D., Lane, D. A., Lotto, R. R., Oxborough, D., Neubeck, L., Penson, P. E., Smith, E. J., Santos, A., McGinn, E. E., Ajiboye, A., et al. (2024) · American Heart Journal · doi:10.1016/j.ahj.2024.02.011 · Cited by 5
Screening for Atrial Fibrillation and the Role of Digital Health Technologies
Richardson, E., Hall, A., & Mitchell, A. R. J. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.88660 · Cited by 6
Zwart, L. A. R., Spruit, J. R., Jansen, R. W. M. M., Riezebos, R. K., Pisters, R., Louter, L., de Vries, K., Taekema, D. G., Wold, J., de Groot, J. R., et al. (2025) · Age and Ageing · doi:10.1093/ageing/afaf105 · Cited by 5
Screening for Atrial Fibrillation: Risks, Benefits, and Implications On Future Clinical Practice
Ilyas, M. H., Sharih, A. M., Jido, J. T., Ali, A. R. Z., Khoshnaghsh, A., Nadeem, M., & Zahra, S. A. (2024) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-024-01047-1 · Cited by 3
“Furthermore, systematic reviews aiming to identify PPG-based devices' accuracy found a pooled sensitivity and specificity of 94% and 96% receptively [60].”
Beerten, S. G., Proesmans, T., & Vaes, B. (2021) · Trials · doi:10.1186/s13063-021-05497-x · Cited by 4
“Examples are heart rate and blood pressure monitors [20], one-lead ECG devices or smartphone apps [21, 22], or event recorder patches [23].”
BackgroundJacobs, M. S., Adeoye, A. M., Owolabi, M. O., Tieleman, R. G., Postma, M. J., & van Hulst, M. (2021) · Global Heart · doi:10.5334/gh.893 · Cited by 4
“9% MyDiagnostick® versus 92%/82% for pulse palpation) [11, 12].”
BackgroundSelf-citationThe involvement of pharmacies in the screening of undiagnosed atrial fibrillation
Modesti, P. A., Donigaglia, G., Fabiani, P., Mumoli, N., Colella, A., & Boddi, M. (2017) · Internal and Emergency Medicine · doi:10.1007/s11739-017-1752-3 · Cited by 5
“The Elba-FA project was thus designed to determine the feasibility and impact of the combined involvement of pharmacies and general practices to screen undiagnosed AF in a confined area of Italy, the Isle of Elba, using innovative ECG technology [35, 36], with the ultimate aim of reducing the burden of stroke and thro…”
MethodDevyashina, K. S., Oganyan, K. G., Panchoyan, S. M., Yakovleva, Y. A., & Frolova, E. V. (2018) · Russian Family Doctor · doi:10.17816/rfd2018214-18 · Cited by 3
“Высокая специфичность прибора [2] к обнаружению ФП предотвращает получение ложноположительных результатов, что минимизирует беспокойство пациента и нагрузку на врача.”
Validation of MyDiagnostick tool to identify atrial fibrillation in a multi-ethnic Asian population
Yeo, C., Mon, A., Tan, V. H., & Wong, K. C. K. (2022) · Singapore Medical Journal · doi:10.11622/smedj.2022028 · Cited by 3
“1%).[10] In comparison, our population had a much lower prevalence of AF (1.”
BackgroundCarvalho, A. P. V., do Carmo, G. A. L., Silva, C. A., Oliveira, A. C. D. S., Perez, L. G., do Carmo, L. P. D. F., & Ribeiro, A. L. P. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20240450i · Cited by 2
2025 Thai guideline for the diagnosis and management of atrial fibrillation
Ngarmukos, T., Methavigul, K., Rungpradubvong, V., Apiyasawat, S., Wongcharoen, W., Pumprueg, S., Boonyapisit, W., Suwanagool, A., Chantrarat, T., Makarawate, P., et al. (2025) · Asian Biomedicine · doi:10.2478/abm-2025-0028 · Cited by 3
“1.5 Handheld ECG devices and smartwatches—Por - table ECG devices that can record ECG conti - nuously for at least 30 s [18].”
InfluentialZink, M. D., Napp, A., & Gramlich, M. (2020) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-020-00711-w · Cited by 3
Poposka, L., Vavlukis, M., Pejkov, H., & Gušev, M. (2021) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2021.4960 · Cited by 2
“Different patient operated devices [2], [3] and prolonged continuous ECG monitoring with skin patches [4] have been tested and validated for detection of different rhythm disturbances in different patient cohorts.”
BackgroundMobile Health zur Detektion von Vorhofflimmern – Status quo und Perspektiven
Lawin, D., Albrecht, U., Oftring, Z. S., Lawrenz, T., Stellbrink, C., & Kühn, S. (2022) · Der Internist · doi:10.1007/s00108-022-01267-2 · Cited by 1
“Die Algorithmen zur Diagnostik von VHF basieren auf künstlicher Intelligenz und stützen sich auf die Irregularität der RR-Intervalle und je nachHersteller auf die fehlende Detektion von P-Wellen [28].”
BackgroundInfluentialMobile ECG Devices Selection: A Comprehensive Review
Sladojević, S., Anderla, A., Gutai, A., Arsenović, M., Sladojević, M., Stevanov, B., Sremčev, N., & Pržulj, Đ. (2024) · Tehnički glasnik · doi:10.31803/tg-20230615143201 · Cited by 2
“According to the study by Tieleman et al. MyDiagnostick has a 100% sensitivity and 95.9% specificity for detection of atrial fibrillation [52].”
InfluentialCarvalho, A. P. V., do Carmo, G. A. L., Silva, C. A., Oliveira, A. C. D. S., Perez, L. G., do Carmo, L. P. D. F., & Ribeiro, A. L. P. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20240450 · Cited by 3
“14 All positive records were later analyzed by the main researcher.”
InfluentialInnovative technologies for the cardiac patient and their effects
Eggett, C. (2015) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2015.10.8.370 · Cited by 1
Use of the electrocardiogram for prediction of arrhythmia outcome in atrial fibrillation
Lankveld, T. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20161117tl · Cited by 1
Feasibility of screening for atrial fibrillation in primary care: Just a heartbeat away?
Orchard, J. J., Lowres, N., Freedman, B., Li, J., & Neubeck, L. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316663547
“In Europe, Tieleman et al.3 concluded that it was feasible to screen patients in a primary care setting using a single-lead ECG (the MyDiagnostick) during influenza vaccination.”
BackgroundVoorkamerfibrillatie in de eerste lijn: Hoe kan de MyDiagnostick® ondersteuning bieden?
Maes, V., Corne, K., Vaes, B., & Degryse, J. (2016) · Huisarts Nu · doi:10.1007/s40954-016-0078-0
Screening for atrial fibrillation in high-risk individuals : a stroke preventive effort
Svennberg, E. (2016) · Figshare
Pidanov, O. Y. (2017) · The Bulletin of Contemporary Clinical Medicine · doi:10.20969/vskm.2017.10(6).24-30 · Cited by 1
“В таких условиях персонализированный событийный мониторинг может существенно улучшить выявляемость нарушений ритма и повысить качество наблюдения и лечения пациентов после хирургического воздействия [11, 12].”
Atrial Fibrillation a Benign Condition? Quality of Life Approach
Ţică, O., Țica, O., Hatos, A., Pantea-Roșan, L. R., & Popescu, M. I. (2018) · Central European Journal of Clinical Research · doi:10.2478/cejcr-2018-0008
“Several patient-operated devices [25] and extended continuous ECG monitoring using skin patch recorders have been validated for the”
BackgroundOpsporen van atriumfibrilleren in de huisartsenpraktijk
Kaasenbrood, F. (2020) · Huisarts en Wetenschap · doi:10.1007/s12445-020-0881-5
Erküner, Ö. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210604oe
van Rosmalen, F. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210113fr
Gurp, N. V.-V., & van Gurp (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20220325nv
Performance of the imPulse device for the detection of atrial fibrillation in hospital settings
McDonagh, S. T. J., Rhodes, S. G., Warren, F. C., Keenan, S., Pentecost, C., Keeling, P. J., James, M. A., Taylor, R. S., & Clark, C. E. (2022) · Cardiovascular Digital Health Journal · doi:10.1016/j.cvdhj.2022.05.002
“Atrial flutter is sometimes excluded from diagnostic accuracy studies; this seems illogical, since both AF and atrial flutter are associated with similar stroke risks, and with each other.(9,19) The current study included people with atrial flutter in all analyses.”
ResultTop Portable ECGs in the Status Quo
Chellarapu, S. A., & Cavanaugh, C. (2023) · Journal of Student Research · doi:10.47611/jsrhs.v11i1.2494 · Cited by 1
Cardiac arrhythmias in geriatric patients receiving palliative care support
Taşar, P., Karaşahin, Ö., Birdal, O., Altınkaya, O., Unes, M., Serin, B. N., Sevinç, C., & Şahin, S. (2023) · Medycyna Paliatywna · doi:10.5114/pm.2023.132768
Research Progress of Wearable 12-Lead ECG Device for Screening Asymptomatic Atrial Fibrillation
优里吐孜, ·. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.142407
Tüm Yönleri ile AF ve Tedavi Yaklaşımları
Çelik, A., Hakgör, A., Çolak, A., Kunak, A. Ü., Sezenöz, B., Şengör, B. G., Arın, C. B., Coşkun, E. Ç., Ersoy, E. I. Y., Aksakal, E., et al. (2022) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.1962
Jones, I. D., Fitzsimmons, D. A., Musa, M. K., Carroll, P., Smith, E. J., Clowes, M., Carr, J., Fulstow, A., Yates, J., & Lip, G. Y. H. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-087974
Research Progress of Screening and Community Management of Atrial Fibrillation
吴, 航. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1572162
Rantula, O., Lipponen, J. A., Halonen, J., Jäntti, H., Rissanen, T. T., Tarvainen, M. P., Naukkarinen, N. S., Väliaho, E., Santala, O. E., Sedha, J., et al. (2026) · JMIR mhealth and uhealth · doi:10.2196/82475 · Cited by 1
WERABLE TECHNOLOGIES IN ATRIAL FIBRILLATION SCREENING: A NARRATIVE REVIEW
Sergejuk, E., Kotlarski, W., Kotlarska, K. M., & Mainka, T. S. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5542
Joung, B., Krittayaphong, R., Guo, Y., Yang, P., Hsieh, Y., Ikeda, T., Kim, D., Kojodjojo, P., Chan, N., Yuniadi, Y., et al. (2026) · Journal of Arrhythmia · doi:10.1002/joa3.70495 · Cited by 2
Metadata
- Authors
- Tieleman, R. G., Plantinga, Y., Rinkes, D., Bartels, G. L., Posma, J. L., Cator, R., Hofman, C., & Houben, R. P.
- Affiliations
- Martini Ziekenhuis (NL)
- Corresponding author
- Tieleman, R. G.
- Venue
- Europace
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-05-13
- Volume
- 16
- Issue
- 9
- Pages
- 1291-1295
- ISSN
- 1099-5129 (ISSN-L)
- 1532-2092
- PMC
- PMC4149608
- OpenAlex
- W2152856261
- Semantic Scholar
- 7410db84a993afb11b9a659aae27177733ee6238
- Cited by
- 138
- References
- 26
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 9 · 2023: 7 · 2022: 18 · 2021: 22 · 2020: 14 · 2019: 8 · 2018: 14 · 2017: 11 · 2016: 20 · 2015: 5
- FWCI
- 8.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- EP Europace (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (submittedVersion, cc-by-nc)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › ECG Monitoring and Analysis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- atrial fibrillation, atrial fibrillation screening, automated ECG analysis, influenza vaccination, general practitioners, undiagnosed atrial fibrillation, CHA2DS2-VASc score, stroke risk, diagnostic accuracy
- MeSH terms
- Aged, Atrial Fibrillation, Diagnosis, Computer-Assisted, Equipment Design, Female, Humans, Male, Mass Screening, Miniaturization, Sensitivity and Specificity, Signal Processing, Computer-Assisted, Reproducibility of Results, Electrocardiography, Ambulatory, Equipment Failure Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.